What is the appropriate workup and treatment for a 36-year-old female with interstitial cystitis?

Workup and Treatment for Interstitial Cystitis in a 36-Year-Old Female

Begin with a thorough clinical history documenting symptoms for at least 6 weeks with negative urine cultures, then perform cystoscopy to determine if Hunner lesions are present—this single finding fundamentally changes your treatment approach. 1

Diagnostic Workup

Essential Initial Evaluation

Document the following specific symptoms:

• Voiding frequency (number of voids per 24 hours using at least a 1-day voiding diary)
• Pain characteristics: location, severity, character, and relationship to bladder filling
• Constant urge sensation even after voiding
• Dyspareunia (painful intercourse)
• Relationship to menstrual cycle 1

Physical Examination Requirements

Perform a brief neurological exam to exclude occult neurologic problems and evaluate for incomplete bladder emptying to rule out retention. 1

Laboratory and Imaging

• Urine culture is mandatory even with negative urinalysis to detect lower bacterial levels not visible on dipstick 1
• Symptoms must be present for at least 6 weeks with documented negative cultures 1
• Consider hematuria workup if tobacco exposure exists (high bladder cancer risk) 1

Critical Decision Point: Cystoscopy

Perform cystoscopy to identify Hunner lesions—this is the only reliable diagnostic finding and determines your entire treatment pathway. 1

The 2022 AUA guidelines emphasize that most patients tolerate office flexible cystoscopy, though some prefer general anesthesia. Importantly, patients with suspected Hunner lesions should undergo cystoscopy early without requiring them to fail other treatments first because they respond well to specific interventions. 1

Common pitfall: Urodynamics are NOT recommended for routine diagnosis unless you suspect outlet obstruction, poor detrusor contractility, or need to explain treatment refractoriness. 1

Treatment Algorithm

The 2022 AUA guidelines abandoned the old first-through-sixth-line tier system in favor of individualized, concurrent multi-modal therapy. 1 However, here's the practical approach:

Step 1: Behavioral and Self-Care (Start Immediately)

Implement these specific modifications:

• Dietary elimination: Avoid common bladder irritants, then use systematic elimination diet to identify personal triggers
• Fluid management: Alter urine concentration/volume through strategic hydration
• Pelvic floor muscle relaxation (NOT strengthening exercises, which may worsen symptoms)
• Bladder training with urge suppression
• Heat or cold application over bladder/perineum for trigger points
• Stress management practices for coping and managing flare-ups 1

Avoid: Tight-fitting clothing, certain exercises (especially pelvic floor strengthening), and address constipation aggressively 1

Step 2: Oral Pharmacotherapy

If Hunner lesions are absent, consider these medications based on evidence strength:

Amitriptyline (Grade B Evidence - Strongest)

• Start at 10 mg and titrate gradually to 75-100 mg if tolerated
• Superior to placebo but expect adverse effects (sedation, drowsiness, nausea) that may compromise quality of life 1

Cimetidine (Grade B Evidence)

• Clinically significant improvement in symptoms, pain, and nocturia
• No adverse effects reported in studies 1

Pentosan Polysulfate (Grade B Evidence - FDA Approved)

• Only FDA-approved oral agent for IC/BPS
• Critical warning: Must counsel patients on potential macular damage and vision-related injuries before initiating or continuing treatment 1
• Evidence is contradictory on effectiveness—discuss benefits and risks thoroughly 1

Hydroxyzine (Grade C Evidence)

• May work better in patients with systemic allergies
• Expect sedation and weakness 1

Step 3: Pain Management Principles

Never rely on pain management alone—it's insufficient as monotherapy. 1 Use a multi-modal approach combining pharmacologic agents with behavioral therapies to treat underlying bladder symptoms.

Opioid caution: Due to the global opioid crisis, use chronic opioids judiciously only after informed shared decision-making, with periodic follow-ups to assess efficacy, adverse events, compliance, and abuse potential. Preferentially use non-opioid alternatives. 1

Step 4: Advanced Therapies (If Refractory)

Consider bladder instillations, procedures (hydrodistension, botulinum toxin injections, sacral neuromodulation), or in severe bladder-centric disease, major surgery. 1, 2

Special Consideration: Hunner Lesions Present

If cystoscopy reveals Hunner lesions, this represents a distinct inflammatory disease requiring different treatment (typically fulguration or excision of lesions). 3, 4 These patients respond well to directed treatment, which is why early cystoscopy is crucial in suspected cases.

Critical Pitfalls to Avoid

1. Don't miss confusable diseases: Bladder cancer occurred in 2.2% of presumed IC patients, with some diagnosed only during follow-up. 5 Maintain vigilance, especially with hematuria or tobacco exposure.

2. Don't forget tuberculosis: Urinary TB was found in 1.1% of IC patients. 5 Consider imaging if suspected.

3. Don't treat empirically with antibiotics for culture-negative "UTI" symptoms—you may be missing IC/BPS diagnosis. 6

4. Don't perform routine urodynamics—they don't establish IC/BPS diagnosis. 1

5. Don't skip the cystoscopy—it's the only way to identify Hunner lesions, which fundamentally changes management. 1